Evidence map›Paper›PMID 24599095›Full record

ArticlePloS one2014

p-Hydroxyphenylpyruvate, an intermediate of the Phe/Tyr catabolism, improves mitochondrial oxidative metabolism under stressing conditions and prolongs survival in rats subjected to profound hemorrhagic shock.

Antonella Cotoia, Rosella Scrima, Julia V Gefter, Claudia Piccoli, Gilda Cinnella, Michele Dambrosio, Mitchell P Fink, Nazzareno Capitanio

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Antonella CotoiaDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Rosella ScrimaDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Julia V GefterDepartment of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Claudia PiccoliDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Gilda CinnellaDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Michele DambrosioDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Mitchell P FinkDepartment of Surgery and Anesthesiology, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America.
Nazzareno CapitanioDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
University of Foggia · ITUniversity of California, Los Angeles · USUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to test the effect of a small volume administration of p-hydroxyphenylpyruvate (pHPP) in a rat model of profound hemorrhagic shock and to assess a possible metabolic mechanism of action of the compound. The results obtained show that hemorrhaged rats treated with 2-4% of the estimated blood volume of pHPP survived significantly longer (p<0.001) than rats treated with vehicle. In vitro analysis on cultured EA.hy 926 cells demonstrated that pHPP improved cell growth rate and promoted cell survival under stressing conditions. Moreover, pHPP stimulated mitochondria-related respiration under ATP-synthesizing conditions and exhibited antioxidant activity toward mitochondria-generated reactive oxygen species. The compound effects reported in the in vitro and in vivo analyses were obtained in the same millimolar concentration range. These data disclose pHPP as an efficient energetic substrates-supplier to the mitochondrial respiratory chain as well as an antioxidant supporting the view that the compound warrants further evaluation as a therapeutic agent.

Indexed as

Stress, PhysiologicalAnimalsCell LineCell ProliferationCell RespirationCell SurvivalHemodynamicsHumansMetabolic Networks and PathwaysMitochondriaOxidation-ReductionPhenylalaninePhenylpyruvic AcidsRatsReactive Oxygen SpeciesShock, Hemorrhagic4-hydroxyphenylpyruvic acidPhenylalaninePhenylpyruvic AcidsReactive Oxygen SpeciesSuperoxidesTyrosine

Identifiers

PMID24599095
PMCPMC3944966
OpenAlexW2059976047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.